Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Operating Margin (2016 - 2025)

Historic Operating Margin for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to 26.61%.

  • Utah Medical Products' Operating Margin fell 68000.0% to 26.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.78%, marking a year-over-year decrease of 23600.0%. This contributed to the annual value of 6.83% for FY2024, which is 21600.0% up from last year.
  • As of Q3 2025, Utah Medical Products' Operating Margin stood at 26.61%, which was down 68000.0% from 32.11% recorded in Q2 2025.
  • Utah Medical Products' 5-year Operating Margin high stood at 40.55% for Q3 2021, and its period low was 26.61% during Q3 2025.
  • Moreover, its 5-year median value for Operating Margin was 34.39% (2023), whereas its average is 34.86%.
  • Per our database at Business Quant, Utah Medical Products' Operating Margin soared by 153100bps in 2021 and then crashed by -79400bps in 2023.
  • Over the past 5 years, Utah Medical Products' Operating Margin (Quarter) stood at 39.72% in 2021, then fell by -6bps to 37.35% in 2022, then fell by -14bps to 31.98% in 2023, then grew by 0bps to 32.0% in 2024, then dropped by -17bps to 26.61% in 2025.
  • Its Operating Margin stands at 26.61% for Q3 2025, versus 32.11% for Q2 2025 and 32.47% for Q1 2025.